Evidence map›Paper›PMID 42300159›Full record

ReviewNatural product reports2026

Inverse stable isotopic labeling for natural product characterization and discovery.

Jose Miguel D Robes, Aaron W Puri

Abstract readReview
In one paragraph

Review in Natural product reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jose Miguel D RobesDepartment of Chemistry and the Henry Eyring Center for Cell and Genome Science, University of Utah, Salt Lake City, UT 84112, Utah, USA. a.puri@utah.edu.ORCID http://orcid.org/0000-0002-5593-712X
Aaron W PuriDepartment of Chemistry and the Henry Eyring Center for Cell and Genome Science, University of Utah, Salt Lake City, UT 84112, Utah, USA. a.puri@utah.edu.ORCID http://orcid.org/0000-0002-6378-678X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covering: 2005 to 2026Stable isotopic labeling is a powerful tool in natural products research; however, the isotopically substituted precursors required for conventional labeling approaches are not always available. In such cases, inverse stable isotopic labeling (InverSIL) offers an effective alternative. In this approach, natural product producing organisms are grown on isotopically substituted media, which is then supplemented with precursors at their natural isotopic abundance. Incorporation of these unlabeled precursors can be readily detected due to their isotopic contrast, circumventing limitations associated with precursor availability. Here, we review applications of InverSIL in the characterization of natural product biosynthetic pathways and structures, as well as its use in genome mining to link biosynthetic genes to the natural products they produce. We also discuss contexts in which the InverSIL approach is particularly advantageous, as well as situations where its utility may be limited. Through this review, we aim to encourage broader adoption of InverSIL as a versatile strategy for advancing natural products research.

Identifiers

PMID42300159
PMCPMC13232609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.